MedTrace Logo

Efficacy and Safety of Digital Therapeutic in Adults With Prediabetes

NCT05668819 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2025-01-10

No results posted yet for this study

Summary

The study aims to evaluate the efficacy and safety of a digital therapeutic (TH-001) for adult individuals with prediabetes.

Conditions

Interventions

DEVICE

TH-001

TH001 is a software program intended to treat adults with prediabetes.

Sponsors & Collaborators

  • Tesu Saglik Teknolojileri A.S.

    lead INDUSTRY

Principal Investigators

  • Ramazan Cakmak, MD · Istinye University Health Practice and Research Center Gaziosmanpasa Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-07
Primary Completion
2024-12-24
Completion
2024-12-24

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05668819 on ClinicalTrials.gov